drugset / Trial / NCT01564134

Dose of Hepatitis B Vaccines in Non/Low-response Populations

NCT01564134 ↗

RandomizedParallel-groupDouble-blindPrevention

Summary

An interventional study will be performed in subjects aged 1-65 years old to evaluate effects of different doses of hepatitis B vaccines in low or non-response population.

Timeline

Start
2011-08
Primary completion
2012-03
Completion
2012-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Hepatitis B vaccine Vaccine 5 ug —
Subject Hepatitis B vaccine Vaccine 10 ug —
Subject Hepatitis B vaccine Vaccine 20 ug —
Subject Hepatitis B vaccine Vaccine 60 ug —

Indications